Product Description: Trazpiroben (TAK-906) is a dopamine D2/D3 receptor antagonist used for chronic research of moderate-to-severe gastroparesis[1].
Applications: Neuroscience-Neuromodulation
Formula: C31H39N3O4
References: [1]Kuo B, Scimia C, Dukes G, Zhang W, Gupta S, Chen C, Chuang E, Camilleri M. Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D2 /D3 receptor antagonist, in patients with gastroparesis. Aliment Pharmacol Ther. 2021 Aug;54(3):267-280.
CAS Number: 1352993-39-5
Molecular Weight: 517.66
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: Dopamine Receptor